Table 1.

AMPKα2, mTOR, ULK1, OXPHOS complex II, III, VI, and V protein content

	MOD				SPRINT
	Before Training/Pre	0 h	2 h	After Training	Before Training/Pre	0 h	2 h	After Training
AMPKα2	1.05 ± 0.09	0.95 ± 0.09	1.16 ± 0.05	0.92 ± 0.09	0.89 ± 0.09	1.03 ± 0.07	0.98 ± 0.07	0.99 ± 0.14
mTOR	0.78 ± 0.14	0.61 ± 0.11	0.75 ± 0.17	0.54 ± 0.14	0.73 ± 0.16	0.64 ± 0.13	0.59 ± 0.05	0.53 ± 0.13
ULK1	0.98 ± 0.28	0.97 ± 0.17	1.01 ± 0.20	1.43 ± 0.36	1.03 ± 0.27	0.82 ± 0.14	0.83 ± 0.09	0.97 ± 0.20
OXPHOS Complex V	1.06 ± 0.1			1 ± 0.1	1.1 ± 0.1			1.2 ± 0.2
OXPHOS Complex III	0.9 ± 0.06			0.8 ± 0.09	0.93 ± 0.06			0.95 ± 0.09
OXPHOS Complex VI	0.69 ± 0.05			0.63 ± 0.08	0.61 ± 0.04			0.72 ± 0.01
OXPHOS Complex II	0.89 ± 0.08			0.69 ± 0.15	1.01 ± 0.15			0.96 ± 0.14

AMPKα2, mTOR, ULK1, OXPHOS complex II, III, VI, and V protein content Pre, immediately after (0 h) and 2 h after 1 h of continuous moderate intensity exercise at 60% of VO₂‐max (MOD) or continuous moderate intensity exercise interspersed with sprints (SPRINT). Values are presented as means ± SE; n = 6.